Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
An investigator-initiated, phase II randomized, double-blind, placebo controlled trial of GDC-0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients.gg Tang, J. Y., Mackay-Wiggan, J. M., Aszterbaum, M., Lindgren, J., Chang, K., Coppola, C., Campbell, A., Chanana, A., Marji, J., Callahan, C., Yauch, R., Bickers, D. R., Epstein, E. H. AMER ASSOC CANCER RESEARCH. 2011
View details for DOI 10.1158/1538-7445.AM2011-LB-1
View details for Web of Science ID 000209701302347